Pathologic Outcomes in Prostate Cancer Cases Worsened During Pandemic
Compared with before the pandemic, men undergoing radical prostatectomy during the pandemic were more likely to have extraprostatic disease, according to investigators.
EAU Congress
Apalutamide Prolongs Survival in mCSPC Regardless of Disease Volume
A final analysis of the TITAN trial shows that apalutamide vs placebo added to ADT significantly lowers the risk of death and castration-resistant disease in men with metastatic castration-sensitive prostate cancer.
PSMA-PET/CT May Detect Prostate Cancer More Accurately Than mpMRI
Early results support a fully-powered trial of 18F-PSMA PET/CT for prostate cancer detection, according to the investigators.
Study: Risk Score Should Guide Deferral of Cytoreductive Nephrectomy
Ideal patient selection for a deferred cytoreductive nephrectomy should include an assessment of Memorial Sloan Kettering Cancer Center risk score, according to investigators.
Photodynamic Diagnosis Ups Detection of BCG-Refractory Bladder Tumors
Photodynamic diagnosis cystoscopy demonstrates greater sensitivity in the detection of BCG-refractor bladder tumors compared with standard white light cystoscopy.
Survival Odds Similar After Open, Robotic-Assisted Radical Cystectomy
Researchers in The Netherlands compared the surgical approaches in patients with muscle-invasive or high-risk nonmuscle-invasive bladder cancer.
Renal Mass Size Could Help Assess Need for Chest Imaging
Synchronous lung metastasis occurs in less than 1% of patients with renal masses less than 4 cm in diameter, so chest imaging in these cases may be unwarranted, according to investigators.
mpMRI Misses Few Significant Prostate Cancers in Re-Biopsied Men
Study findings lend support to using mpMRI for prostate cancer detection.
Obesity Linked to Lower Death Risk in mCRPC
Obesity in men with metastatic castration-resistant prostate cancer is associated with decreased risks for all-cause and cancer-specific mortality compared with overweight and normal-weight men.
Women Have Worse Oncologic Outcomes in High-Risk NMIBC
Among patients with high-risk pTa bladder cancer, female sex was significantly associated with a higher risk for stage progression compared with male sex.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in EAU Congress
Loading... 
Loading...